Exchange: NASDAQ·Updated 07:31 PM EST

About SNDX

About

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include Revuforj and Niktimvo. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
298

Frequently Asked Questions

Advertisement|Remove ads.